MBRX | Moleculin Biotech Inc
Category: Consumer goods
Quick infos Headquarters: Houston, Texas, United States Trade prices Volume: Market Cap: 118.8M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: May 18, 2021
Earnings History Date EPS / Forecast Revenue / Forecast May 18, 2021 April 5, 2021 - / -0.5667- / -March 24, 2021 -0.28 / -0.5767- / -November 13, 2020 -0.36 / -0.0933- / -August 12, 2020 -0.17 / -0.09- / -view more
Historical Data Date Price Open High Low Vol Change ER Apr 1, 2021 4.0600 4.0300 4.0900
3.9500
1.25M -0.49% Mar 31, 2021 4.0800 4.1000 4.1400
3.9100
1.85M -4% Mar 30, 2021 4.2500 4.4800 4.7500
4.0700
31.37M 14.86% Mar 29, 2021 3.7000 3.8500 3.8500
3.6600
350.44K -3.39% Mar 26, 2021 3.8300 3.9300 4.0000
3.7500
313.41K -1.79% Mar 25, 2021 3.9000 3.7300 3.9700
3.7300
377.41K 2.36% Mar 24, 2021 3.8100 4.0200 4.0600
3.7500
591.82K -3.79% Mar 23, 2021 3.9600 4.2500 4.2500
3.9000
615.23K -6.38% Mar 22, 2021 4.2300 4.1500 4.2300
4.1500
291.55K 2.42% Mar 19, 2021 4.1300 4.2500 4.3400
4.1300
1.45M -2.13% view more
News
Moleculin Biotech EPS misses by $0.08 seekingalpha.com Aug 12, 2020 7:38 pm Moleculin's WP1122 shows anti-SARS-CoV-2 effect in new lab tests seekingalpha.com Jul 21, 2020 8:54 pm Moleculin inks production deal for COVID-19 candidate WP1122 seekingalpha.com Jul 15, 2020 8:06 pm
Moleculin Announces Additional Positive Safety Data in EU AML Trial finance.yahoo.com Apr 2, 2020 5:04 pm
Moleculin to Present at the Life Sciences Investor Forum finance.yahoo.com Mar 24, 2020 8:03 am
WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications finance.yahoo.com Mar 24, 2020 8:03 am Moleculin Bio +15% premarket on filing new patent for Covid-19 drug candidate seekingalpha.com Mar 20, 2020 12:03 pm Moleculin Biotech up 48% on potential of candidates against coronavirus seekingalpha.com Mar 17, 2020 3:03 pm
18 Healthcare Stocks Moving In Tuesday's Pre-Market Session benzinga.com Mar 17, 2020 3:03 pm Moleculin Biotech's Annamycin shows favorable safety profile in studies seekingalpha.com Feb 20, 2020 2:02 pm Moleculin Bio updates on annamycin development seekingalpha.com Jul 2, 2020 8:01 pm Moleculin reports encouraging annamycin data in in lung metastases seekingalpha.com Jun 25, 2020 8:56 pm Moleculin Bio confirms antiviral potential of WP1122 seekingalpha.com Jun 16, 2020 8:37 pm Dosing underway in study of Moleculin Bio's WP1066 in pediatric brain tumor seekingalpha.com Jun 2, 2020 8:08 pm Moleculin Bio to resume Nasdaq trading seekingalpha.com May 28, 2020 7:28 pm Moleculin shares halted seekingalpha.com May 18, 2020 9:38 pm Moleculin Bio up 6% premarket on WP1122 deal for COVID-19 seekingalpha.com Apr 20, 2020 8:29 pm Moleculin Biotech to hold investor call on April 16; shares up 12% premarket seekingalpha.com Apr 14, 2020 7:52 pm CNS Pharma up 19% premarket on development of COVID-19 candidates seekingalpha.com Apr 9, 2020 9:07 pm Moleculin Biotech rockets on potential COVID-19 treatment seekingalpha.com Apr 8, 2020 8:07 pm Talk about Moleculin Biotech Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
